This item requires a subscription to Diabetes Care.
Full Text
Original Research - Emerging Treatments and Technologies:
Julio Rosenstock,
Jane Reusch,
Mark Bush,
Fred Yang,
Murray Stewart,
and for the Albiglutide Study Group
Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes: A randomized controlled trial exploring weekly, biweekly, and monthly dosing Diabetes Care October 2009 32:1880-1886; published ahead of print July 10, 2009, doi:10.2337/dc09-0366